Toronto, Canada-based Fullscript has announced the acquisition of Rupa Health, a San Francisco, California-based company that helps practitioners order, track and manage more than 3,000 laboratory tests in a single interface.
Launched in 2020, Rupa Health’s platform modernizes the logistics of lab work by integrating test ordering, results management and patient communication for clinics across the United States. This makes it easier for healthcare providers to access a wide range of diagnostic tools and deliver more personalized care. Today, the company serves tens of thousands of clinics.
Founded in 2011, Fullscript provides supplement delivery and virtual care tools for integrative medicine practitioners and their patients. Fullscript’s software allows integrated medicine practitioners to write virtual treatment plans, dispense supplements and provide adherence tools and evidence-based resources to their patients. The company provides more than 100,000 providers and 10 million patients access to personalized and effective care. In November 2021, private equity firms HGGC and Snapdragon Capital Partners made an approximately $240 million strategic growth investment in Fullscript.
By combining Rupa Health’s best-in-class lab and educational platform with Fullscript’s whole person care platform, Fullscript will be able to quickly scale and expand its comprehensive platform for whole person care. The terms of the acquisition were not disclosed.
According to data captured in the LevinPro HC database, this transaction marks the 93rd Laboratories, MRI and Dialysis acquisition of 2024. There were 126 deals announced in the sector during 2023, and 140 announced during 2022. This also marks Fullscript’s second deal tracked in the LevinPro HC databased. The company had previously acquired Emerson Ecologics, a leading distributor of vitamins, supplements and natural health products, in March 2022 for an undisclosed price.
